ACE and type 2 diabetes mellitus: Secondly, we used a fructose-diet-induced T2D model to investigate whether ACE inhibitor treatment by Ena, commonly used to treat hypertension in T2D, provides benefits for cardiac Ca2+i handling in diabetic heart failure, and if these benefits occur independently of blood pressure reduction, potentially indicating the relevance of local RAS in the process.